BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35205333)

  • 1. Unraveling Gut Microbiota Signatures Associated with PPARD and PARGC1A Genetic Polymorphisms in a Healthy Population.
    Bailén M; Tabone M; Bressa C; Lominchar MGM; Larrosa M; González-Soltero R
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.
    Stefan N; Thamer C; Staiger H; Machicao F; Machann J; Schick F; Venter C; Niess A; Laakso M; Fritsche A; Häring HU
    J Clin Endocrinol Metab; 2007 May; 92(5):1827-33. PubMed ID: 17327385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Andrulionyte L; Peltola P; Chiasson JL; Laakso M;
    Diabetes; 2006 Jul; 55(7):2148-52. PubMed ID: 16804087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there an interaction between PPARD T294C and PPARGC1A Gly482Ser polymorphisms and human endurance performance?
    Eynon N; Meckel Y; Alves AJ; Yamin C; Sagiv M; Goldhammer E; Sagiv M
    Exp Physiol; 2009 Nov; 94(11):1147-52. PubMed ID: 19666693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
    Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
    Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE I/D, ACTN3 R577X, PPARD T294C and PPARGC1A Gly482Ser polymorphisms and physical fitness in Taiwanese late adolescent girls.
    Chiu LL; Chen TW; Hsieh SS; Hsieh LL
    J Physiol Sci; 2012 Mar; 62(2):115-21. PubMed ID: 22247001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha promoter polymorphisms are associated with early-onset type 2 diabetes mellitus in the Korean population.
    Kim JH; Shin HD; Park BL; Cho YM; Kim SY; Lee HK; Park KS
    Diabetologia; 2005 Jul; 48(7):1323-30. PubMed ID: 15937669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level.
    Zhu L; Huang Q; Xie Z; Kang M; Ding H; Chen B; Chen Y; Liu C; Wang Y; Tang W
    Oncotarget; 2017 Jun; 8(23):37308-37320. PubMed ID: 28418876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene variants in PPARD and PPARGC1A are associated with timing of natural menopause in the general Japanese population.
    Uemura H; Hiyoshi M; Arisawa K; Yamaguchi M; Naito M; Kawai S; Hamajima N; Matsuo K; Taguchi N; Takashima N; Suzuki S; Hirasada K; Mikami H; Ohnaka K; Yoshikawa A; Kubo M; Tanaka H;
    Maturitas; 2012 Apr; 71(4):369-75. PubMed ID: 22310107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population.
    Zhu S; Liu Y; Wang X; Wu X; Zhu X; Li J; Ma J; Gu HF; Liu Y
    Diabetes Res Clin Pract; 2009 Dec; 86(3):168-72. PubMed ID: 19828207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population.
    Nikitin AG; Chistiakov DA; Minushkina LO; Zateyshchikov DA; Nosikov VV
    Heart Vessels; 2010 May; 25(3):229-36. PubMed ID: 20512451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) gene polymorphisms and type 2 diabetes mellitus: a meta-analysis.
    Yang Y; Mo X; Chen S; Lu X; Gu D
    Diabetes Metab Res Rev; 2011 Feb; 27(2):177-84. PubMed ID: 21294239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of the peroxisome proliferator-activated receptor-γ (rs1801282) and its coactivator-1 (rs8192673) are associated with obesity indexes in subjects with type 2 diabetes mellitus.
    Kruzliak P; Haley AP; Starcevic JN; Gaspar L; Petrovic D
    Cardiovasc Diabetol; 2015 Apr; 14():42. PubMed ID: 25928419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA sequence variants in PPARGC1A, a gene encoding a coactivator of the ω-3 LCPUFA sensing PPAR-RXR transcription complex, are associated with NV AMD and AMD-associated loci in genes of complement and VEGF signaling pathways.
    SanGiovanni JP; Chen J; Sapieha P; Aderman CM; Stahl A; Clemons TE; Chew EY; Smith LE
    PLoS One; 2013; 8(1):e53155. PubMed ID: 23335958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic study between SIRT1, PPARD, PGC-1alpha genes and Alzheimer's disease.
    Helisalmi S; Vepsäläinen S; Hiltunen M; Koivisto AM; Salminen A; Laakso M; Soininen H
    J Neurol; 2008 May; 255(5):668-73. PubMed ID: 18438697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose levels and genetic variants across transcriptional pathways: interaction effects with BMI.
    Povel CM; Feskens EJ; Imholz S; Blaak EE; Boer JM; Dollé ME
    Int J Obes (Lond); 2010 May; 34(5):840-5. PubMed ID: 20125101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms of peroxisome proliferator activated receptors in early and late onset of type 2 diabetes mellitus.
    Raj R; Bhatti JS; Bhadada SK; Ramteke PW
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S287-S293. PubMed ID: 28292576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in the peroxisome proliferator-activated receptor (PPAR) and peroxisome proliferator-activated receptor gamma co-activator 1 (PGC1) gene families and type 2 diabetes.
    Villegas R; Williams SM; Gao YT; Long J; Shi J; Cai H; Li H; Chen CC; Tai ES; ; Hu F; Cai Q; Zheng W; Shu XO
    Ann Hum Genet; 2014 Jan; 78(1):23-32. PubMed ID: 24359475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes].
    Su Y; Peng SB; Li ZQ; Huang QY
    Yi Chuan; 2008 Mar; 30(3):304-8. PubMed ID: 18331997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor delta (PPARD) genetic variation and type 2 diabetes in middle-aged Chinese women.
    Villegas R; Williams S; Gao Y; Cai Q; Li H; Elasy T; Cai H; Edwards T; Xiang YB; Zheng W; Long J; Ou Shu X
    Ann Hum Genet; 2011 Sep; 75(5):621-9. PubMed ID: 21834910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.